検索結果

mbination eye drops Senju Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Shuhei Yoshida) announced today that it has obtained approval for a partial change in the marketing authorizatio...

Mytear EYETECT ALPITATTO | OTC Products, etc. | Products | SENJU Pharmaceutical

ease such as glaucoma.) If there is no improvement in your symptoms after using this medicine for 2 days. If you use this medicine for more than 2 weeks even after there is an improvement. *Registered...

Overseas Activities | SENJU Pharmaceutical

al activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we enter the era of globalization, our overseas activities are now diverse. In addition t...

Mytear EYETECT ALPITATTO N | OTC Products, etc. | Products | SENJU Pharmaceutical

ease such as glaucoma.) If there is no improvement in your symptoms after using this medicine for 2 days. If you use this medicine for more than 2 weeks even after there is an improvement. *Registered...

tear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketing of “Mytear Lumify” (OTC drug req...